Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Pfizer Inc.

Thu Feb 2, 2012 9:00am EST

* Reuters is not responsible for the content in this press release.

This morning, announced new reports
highlighting Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and
Pfizer Inc. (NYSE: PFE). Free research downloads are available at

    Economic fundamentals leading into 2012 have set a generally positive
pace with GDP growth likely to pick up through the coming year. However,
there are several important caveats to note as the world economy
continues to face headwinds and risks weigh to the downside. Positive
outlooks are conditional on fiscal policy in payroll taxes and
unemployment insurance benefits and upon the easing of the European debt
situation. A repeat of volatility experienced in 2011 is likely in 2012,
as perceptions about the strength of the U.S. economy and the euro zone
will vary over time as events unfold.

    Despite the current situation, our team continues to identify high
momentum situations with growth potential -- there remains strong
opportunity within careful discretion.

    Market Foundations is releasing new coverage on Vertex Pharmaceuticals
Incorporated for its current position within the healthcare industry.
Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business
of discovering, developing and commercializing small molecule drugs for
the treatment of diseases. The full research report on Vertex
Pharmaceuticals Incorporated (NASDAQ: VRTX) is available here:

    Market Foundations has released research on Pfizer Inc. for its changing
role within the healthcare industry. Pfizer Inc. is a research-based,
global biopharmaceutical company. The full research report on Pfizer Inc.
(NYSE: PFE) is available here:

    About Market Foundations
 By providing members with financial information
services, we provide the foundation investors need to build investing
intelligence. The difference between consistently making good investments
or bad investments is nothing more than the right information at the
right time.



Gemma Cunningham

Copyright 2012, Market Wire, All rights reserved.